# Pedro Romero

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/pedro-romero/

## Facts

| Field | Value |
| --- | --- |
| Citations | 38,142 |
| Field | Immunotherapy and Immune Responses |
| h-index | 101 |
| i10-index | 319 |
| Last Known Institution | TiGenix (Spain) |
| OpenAlex ID | https://openalex.org/A5101424852 |
| ORCID iD | https://orcid.org/0000-0002-9688-2882 |
| Works | 683 |

## Researcher papers

- [The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis](https://scholariq.org/papers/the-antimicrobial-peptide-ll37-is-a-t-cell-autoantigen-in-psoriasis/)
- [Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity](https://scholariq.org/papers/metabolic-reprogramming-of-terminally-exhausted-cd8-t-cells-by-il-10-enhances/)
- [Defining the critical hurdles in cancer immunotherapy](https://scholariq.org/papers/defining-the-critical-hurdles-in-cancer-immunotherapy/)

## Researcher topics

- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

## Researcher university

- [TiGenix (Spain)](https://scholariq.org/institutions/tigenix-spain/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.